Home » Companies
Virtus Stone Harbor Emerging Markets Total Income Fund Announces Monthly Dividend of $0.07 (NYSE:EDI)
Virtus Stone Harbor Emerging Markets Total Income Fund (NYSE:EDI – Get Rating) announced a monthly dividend on Friday, May 27th, Wall Street Journal reports. Shareholders of record on Tuesday, July 12th will be given a dividend... More of this article »
ASGN (NYSE:ASGN) Lowered to Hold at Zacks Investment Research
ASGN (NYSE:ASGN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “ASGN... More of this article »
Avid Technology (NASDAQ:AVID) Upgraded to Buy by Zacks Investment Research
Avid Technology (NASDAQ:AVID – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Friday, Zacks.com reports. The brokerage currently... More of this article »
Zacks Investment Research Upgrades ASE Technology (NYSE:ASX) to “Hold”
ASE Technology (NYSE:ASX – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks,... More of this article »
Biofrontera (NASDAQ:BFRI) Downgraded by Zacks Investment Research
Biofrontera (NASDAQ:BFRI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Biofrontera... More of this article »
Aura Biosciences (NASDAQ:AURA) Rating Lowered to Hold at Zacks Investment Research
Aura Biosciences (NASDAQ:AURA – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday, Zacks.com reports. According to Zacks,... More of this article »
Altus Power (NYSE:AMPS) Stock Rating Lowered by Zacks Investment Research
Altus Power (NYSE:AMPS – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “Altus... More of this article »
Movado Group (NYSE:MOV) Issues Quarterly Earnings Results
Movado Group (NYSE:MOV – Get Rating) issued its quarterly earnings data on Thursday. The company reported $0.82 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.36, MarketWatch Earnings reports.... More of this article »
Investment Analysts’ Updated EPS Estimates for May 27th (AAWH, ABEO, ACH, ACHR, ADMP, ADSE, AFLYY, AMAM, AMPS, CGC)
Investment Analysts’ updated eps estimates for Friday, May 27th: Ascend Wellness (OTC:AAWH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ascend Wellness... More of this article »
Stock Analysts’ Price Target Changes for May 27th (ACHL, ADEVF, ANPCY, ATDRY, ATGSY, AVDL, BKKVF, BMEA, BNDSF, BNTGY)
Stock Analysts’ price target changes for Friday, May 27th: Achilles Therapeutics (NASDAQ:ACHL) had its target price trimmed by Piper Sandler from $17.00 to $10.00. Adevinta ASA (OTCMKTS:ADEVF) had its price target reduced by... More of this article »
First Trust Dorsey Wright International Focus 5 ETF (NASDAQ:IFV) Short Interest Up 101.7% in May
First Trust Dorsey Wright International Focus 5 ETF (NASDAQ:IFV – Get Rating) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 12,100 shares,... More of this article »
iPower Inc. (NASDAQ:IPW) Short Interest Down 60.9% in May
iPower Inc. (NASDAQ:IPW – Get Rating) saw a large decrease in short interest in May. As of May 15th, there was short interest totalling 181,200 shares, a decrease of 60.9% from the April 30th total of 462,900 shares. Currently,... More of this article »
ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS) Short Interest Update
ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS – Get Rating) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 35,900 shares, a growth of 100.6% from the April... More of this article »
Hudson Technologies, Inc. (NASDAQ:HDSN) Sees Significant Growth in Short Interest
Hudson Technologies, Inc. (NASDAQ:HDSN – Get Rating) was the target of a large increase in short interest in May. As of May 15th, there was short interest totalling 1,330,000 shares, an increase of 105.3% from the April 30th... More of this article »
Maxar Technologies (MAXR) – Investment Analysts’ Recent Ratings Changes
A number of research firms have changed their ratings and price targets for Maxar Technologies (NYSE: MAXR): 5/26/2022 – Maxar Technologies had its price target raised by analysts at TD Securities from $43.00 to $45.00. They... More of this article »
Sumo Logic (NASDAQ:SUMO) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS
Sumo Logic (NASDAQ:SUMO – Get Rating) issued its quarterly earnings data on Thursday. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.17) by $0.04, Briefing.com reports.... More of this article »
Piper Sandler Cuts ImmunityBio (NASDAQ:IBRX) Price Target to $10.00
ImmunityBio (NASDAQ:IBRX – Get Rating) had its target price reduced by equities researchers at Piper Sandler from $20.00 to $10.00 in a report released on Friday, The Fly reports. Piper Sandler’s price target points to... More of this article »
Piper Sandler Trims Neoleukin Therapeutics (NASDAQ:NLTX) Target Price to $6.00
Neoleukin Therapeutics (NASDAQ:NLTX – Get Rating) had its target price cut by Piper Sandler from $25.00 to $6.00 in a note issued to investors on Friday, The Fly reports. Separately, Zacks Investment Research downgraded shares... More of this article »
Piper Sandler Cuts Leap Therapeutics (NASDAQ:LPTX) Price Target to $4.00
Leap Therapeutics (NASDAQ:LPTX – Get Rating) had its target price reduced by equities researchers at Piper Sandler from $6.00 to $4.00 in a research note issued to investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Marker Therapeutics (NASDAQ:MRKR) Price Target Lowered to $1.50 at Piper Sandler
Marker Therapeutics (NASDAQ:MRKR – Get Rating) had its price objective cut by investment analysts at Piper Sandler from $3.50 to $1.50 in a research report issued to clients and investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Gracell Biotechnologies (NASDAQ:GRCL) Price Target Cut to $10.00 by Analysts at Piper Sandler
Gracell Biotechnologies (NASDAQ:GRCL – Get Rating) had its target price reduced by equities research analysts at Piper Sandler from $25.00 to $10.00 in a report released on Friday, The Fly reports. Piper Sandler’s price... More of this article »
Cardiff Oncology (NASDAQ:CRDF) PT Lowered to $7.00
Cardiff Oncology (NASDAQ:CRDF – Get Rating) had its target price lowered by Piper Sandler from $20.00 to $7.00 in a research note issued on Friday, The Fly reports. Piper Sandler’s target price would indicate a potential... More of this article »
Piper Sandler Cuts Achilles Therapeutics (NASDAQ:ACHL) Price Target to $10.00
Achilles Therapeutics (NASDAQ:ACHL – Get Rating) had its price target cut by analysts at Piper Sandler from $17.00 to $10.00 in a research report issued to clients and investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Ocular Therapeutix (NASDAQ:OCUL) PT Lowered to $10.00
Ocular Therapeutix (NASDAQ:OCUL – Get Rating) had its price objective cut by equities researchers at Piper Sandler from $16.00 to $10.00 in a research report issued to clients and investors on Friday, The Fly reports. Piper... More of this article »
I-Mab (NASDAQ:IMAB) PT Lowered to $35.00 at Piper Sandler
I-Mab (NASDAQ:IMAB – Get Rating) had its price target decreased by Piper Sandler from $80.00 to $35.00 in a report released on Friday, The Fly reports. Piper Sandler’s price target points to a potential upside of 323.22%... More of this article »
CytomX Therapeutics (NASDAQ:CTMX) PT Lowered to $10.00 at Piper Sandler
CytomX Therapeutics (NASDAQ:CTMX – Get Rating) had its price target dropped by investment analysts at Piper Sandler from $16.00 to $10.00 in a research note issued to investors on Friday, The Fly reports. A number of other analysts... More of this article »
Piper Sandler Lowers Oyster Point Pharma (NASDAQ:OYST) Price Target to $15.00
Oyster Point Pharma (NASDAQ:OYST – Get Rating) had its target price dropped by equities research analysts at Piper Sandler from $60.00 to $15.00 in a research note issued to investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Craig Hallum Cuts Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target to $15.50
Avadel Pharmaceuticals (NASDAQ:AVDL – Get Rating) had its price target lowered by analysts at Craig Hallum from $20.00 to $15.50 in a research note issued to investors on Friday, The Fly reports. Several other research firms... More of this article »
Harpoon Therapeutics (NASDAQ:HARP) PT Lowered to $9.00
Harpoon Therapeutics (NASDAQ:HARP – Get Rating) had its price objective lowered by research analysts at Piper Sandler from $14.00 to $9.00 in a research report issued on Friday, The Fly reports. Piper Sandler’s price objective... More of this article »
Piper Sandler Trims Rain Therapeutics (NASDAQ:RAIN) Target Price to $12.00
Rain Therapeutics (NASDAQ:RAIN – Get Rating) had its price objective dropped by analysts at Piper Sandler from $26.00 to $12.00 in a research report issued to clients and investors on Friday, The Fly reports. Piper Sandler’s... More of this article »
Biomea Fusion (NASDAQ:BMEA) PT Lowered to $16.00
Biomea Fusion (NASDAQ:BMEA – Get Rating) had its target price reduced by investment analysts at Piper Sandler from $25.00 to $16.00 in a report released on Friday, The Fly reports. Piper Sandler’s price target points to... More of this article »
Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Short Interest Down 59.9% in May
Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Get Rating) saw a significant decline in short interest in May. As of May 15th, there was short interest totalling 54,500 shares, a decline of 59.9% from the April 30th total... More of this article »
Mountain Crest Acquisition Corp. III (NASDAQ:MCAE) Sees Large Drop in Short Interest
Mountain Crest Acquisition Corp. III (NASDAQ:MCAE – Get Rating) was the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totalling 900 shares, a decrease of 59.1% from the April... More of this article »
MINISO Group (NYSE:MNSO) Issues Quarterly Earnings Results
MINISO Group (NYSE:MNSO – Get Rating) released its earnings results on Thursday. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.49 by ($0.13), Fidelity Earnings reports. MINISO... More of this article »
Manchester United (NYSE:MANU) Releases Earnings Results, Misses Estimates By $13.63 EPS
Manchester United (NYSE:MANU – Get Rating) released its quarterly earnings data on Thursday. The company reported ($13.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($13.63),... More of this article »
Movado Group (NYSE:MOV) Releases Earnings Results, Beats Estimates By $0.36 EPS
Movado Group (NYSE:MOV – Get Rating) issued its earnings results on Thursday. The company reported $0.82 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.36, MarketWatch Earnings reports. Movado... More of this article »
StepStone Group (NASDAQ:STEP) Announces Quarterly Earnings Results
StepStone Group (NASDAQ:STEP – Get Rating) released its earnings results on Thursday. The company reported $0.38 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.02), Briefing.com reports. The firm had revenue... More of this article »
Weekly Investment Analysts’ Ratings Updates for CME Group (CME)
CME Group (NASDAQ: CME) has recently received a number of price target changes and ratings updates: 5/25/2022 – CME Group was upgraded by analysts at Oppenheimer Holdings Inc. from a “market perform” rating to an... More of this article »
JD.com (JD) – Investment Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for JD.com (NASDAQ: JD): 5/26/2022 – JD.com was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating. 5/24/2022... More of this article »
Rio Tinto Group (RIO) – Research Analysts’ Weekly Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of Rio Tinto Group (LON: RIO) in the last few weeks: 5/23/2022 – Rio Tinto Group had its “hold” rating reaffirmed by analysts at... More of this article »
Bloomin’ Brands (NASDAQ:BLMN) vs. Portillo’s (NASDAQ:PTLO) Head-To-Head Survey
Portillo’s (NASDAQ:PTLO – Get Rating) and Bloomin’ Brands (NASDAQ:BLMN – Get Rating) are both small-cap retail/wholesale companies, but which is the better stock? We will compare the two companies based on the... More of this article »
Samsara (NYSE:IOT) & Digimarc (NASDAQ:DMRC) Head to Head Contrast
Digimarc (NASDAQ:DMRC – Get Rating) and Samsara (NYSE:IOT – Get Rating) are both industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings,... More of this article »
Contrasting Avista (NYSE:AVA) & Via Renewables (NASDAQ:VIA)
Avista (NYSE:AVA – Get Rating) and Via Renewables (NASDAQ:VIA – Get Rating) are both utilities companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations,... More of this article »
Potbelly (NASDAQ:PBPB) vs. FAT Brands (NASDAQ:FATBB) Critical Comparison
Potbelly (NASDAQ:PBPB – Get Rating) and FAT Brands (NASDAQ:FATBB – Get Rating) are both small-cap retail/wholesale companies, but which is the better business? We will compare the two companies based on the strength of... More of this article »
Comparing Sunshine Biopharma (NASDAQ:SBFM) and Incyte (NASDAQ:INCY)
Incyte (NASDAQ:INCY – Get Rating) and Sunshine Biopharma (NASDAQ:SBFM – Get Rating) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional... More of this article »
Reviewing Crown (NYSE:CCK) and Ball (NYSE:BALL)
Crown (NYSE:CCK – Get Rating) and Ball (NYSE:BALL – Get Rating) are both large-cap industrial products companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional... More of this article »
Contrasting Convey Health Solutions (CNVY) & Its Rivals
Convey Health Solutions (NYSE:CNVY – Get Rating) is one of 29 publicly-traded companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it compare to its competitors?... More of this article »
Reviewing Quantum-Si (QSI) and Its Competitors
Quantum-Si (NASDAQ:QSI – Get Rating) is one of 28 public companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it weigh in compared to its rivals? We will compare... More of this article »